BioFocus
BioFocus provides innovative drug discovery that delivers targets, hits, leads and clinical candidates in all major therapeutic areas.
We employ over 200 industry experienced scientists at our research centers in the UK and the Netherlands, with business development offices in Hong Kong, Japan and the US.
Since its foundation in 1997, BioFocus has produced high quality data for its clients and this quality is assured by ISO9001 qualification.
BioFocus is a service division of Galapagos NV. Galapagos’ drug discovery division develops novel and disease-modifying drugs in a number of therapeutic areas for which there is a need for better medicines.
Latest news
News
BioFocus Expands Ion Channel Offering Through Agreement with ChanTest
06 Feb 2013
-
University of Nottingham and BioFocus Sign Compound Management Agreement
21 Mar 2011
-
New Collaboration to Discover Novel Targets in the Field of Autoimmune Disease
11 Jan 2011
-
New Compound Libraries from BioFocus
27 Sep 2010
-
BioFocus Launches Four Compound Libraries Targeting Kinases and Protein-Protein Interactions
13 Apr 2010
